Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTO-201 in Pediatric AOMT
NCT02719158Phase 2Completed
- Sponsor
- Otonomy, Inc.
- Start
- Feb 2016
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OTO-201 in acute otitis media (AOM), sponsored by Otonomy, Inc.. Started Feb 2016; status: completed.
02
Drugs
OTO-201
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT02719158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02719158.